Tempest Therapeutics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2017 | $-20.3M | $-20.3M | $4.0K | $6.9M |
| FY2018 | $-23.6M | $-23.7M | $36.0K | — |
| FY2019 | $-41.2M | $-41.6M | $397.0K | — |
| FY2020 | $-19.0M | $-19.1M | $50.0K | — |
| FY2021 | $-26.0M | $-26.1M | $135.0K | — |